Exon duplication and divergence in the human preproglucagon gene
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, GIP-driven weight loss is synergistically enhanced by adjunct GLP-1R agonism47-49”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [49]
In the citing paper
“and while GIP-mediated weight loss is fully preserved in Glp1r-deficient mice45,49”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [49]
In the citing paper
“GIP-driven weight loss is also synergistically enhanced by adjunct GLP-1R agonism47-49,117.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [49]
In the citing paper
“GIPR agonist treatment is equally effective in promoting weight loss in obese mice”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [49]
Citations
Cites
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
[57] Sequencing end-labeled DNA with base-specific chemical cleavages
Maxam, A. M., & Gilbert, W. (1980) · Methods in Enzymology · doi:10.1016/s0076-6879(80)65059-9 · Cited by 14,315
Organization and Expression of Eucaryotic Split Genes Coding for Proteins
Breathnach, R., & Chambon, P. (1981) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.50.070181.002025 · Cited by 4,548
Atlas of protein sequence and structure
Chang, M.-Y., Dayhoff, M. O., Eck, R. V., & Sochard, M. R. (1965) · NASA Technical Reports Server (NASA) · Cited by 4,383
A catalogue of splice junction sequences
Mount, S. M. (1982) · Nucleic Acids Research · doi:10.1093/nar/10.2.459 · Cited by 3,797
Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing
Sanger, F., Coulson, A. R., Barrell, B. G., Smith, A. J. H., & Roe, B. A. (1980) · Journal of Molecular Biology · doi:10.1016/0022-2836(80)90196-5 · Cited by 3,407
Wahl, G. M., Stern, M., & Stark, G. R. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.8.3683 · Cited by 3,247
Gilbert, W. (1978) · Nature · doi:10.1038/271501a0 · Cited by 2,300
Atlas of Protein Sequence and Structure, 1966.
Hersh, R. T., Eck, R. V., & Dayhoff, M. O. (1967) · Systematic Zoology · doi:10.2307/2412074 · Cited by 1,779
The structure and evolution of the human β-globin gene family
Efstratiadis, A. (1980) · Cell · doi:10.1016/0092-8674(80)90429-8 · Cited by 1,375
Research works printed but not linked: 2
- Unger, R. H.& Orci, L. (eds) Glucagon, Physiology, Pathophysiology and Morphology of the Pancreatic A-cell (Elsevier, New York, 1981).
- O'Farrell, P. Focus 3 (3), 1–3 (1981).
Cited by
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Glucagon-like peptide-1 7–36: a physiological incretin in man
Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
“Two glucagon-related peptides were subsequently identified in the rat [47,48], hamster [49], bovine [50], and human [51] proglucagon sequence.”
BackgroundGLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art
Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101102 · Cited by 1,647
“Based on the proglucagon nucleotide sequence, prior assumptions regarding processing enzymes led to an erroneous GLP-1 sequence longer by 6 Nterminal amino acid residues [3].”
MethodGLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
Meier, J. J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.140 · Cited by 1,311
Kieffer, T. J., & Francis Habener, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
Incretin hormones: Their role in health and disease
Nauck, M. A., & Meier, J. J. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13129 · Cited by 950
Thorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906
Drucker, D. J., Philippe, J., Mojsov, S., Chick, W. L., & Habener, J. F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3434 · Cited by 903
Mojsov, S., Weir, G. C., & Habener, J. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112855 · Cited by 882
Induction of intestinal epithelial proliferation by glucagon-like peptide 2.
Drucker, D. J., Erlich, P., Asa, S. L., & Brubaker, P. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7911 · Cited by 880
Nauck, M. A., Niedereichholz, U., Ettler, R., Holst, J. J., Ørskov, C., Ritzel, R., & Schmiegel, W. H. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.5.e981 · Cited by 817
Rates of DNA sequence evolution differ between taxonomic groups.
Britten, R. J. (1986) · Science · doi:10.1126/science.3082006 · Cited by 782
Sherwood, N. M., Krueckl, S. L., & McRory, J. E. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0414 · Cited by 726
Mojsov, S., Heinrich, G., Wilson, I. B., Ravazzola, M., Orci, L., & Habener, J. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67324-7 · Cited by 724
α-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Gromada, J., Franklin, I., & Wollheim, C. B. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0007 · Cited by 581
Enhancing Incretin Action for the Treatment of Type 2 Diabetes
Drucker, D. J. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2929 · Cited by 579
Steinert, R. E., Feinle-Bisset, C., Asarian, L., Horowitz, M., Beglinger, C., & Geary, N. (2017) · Physiological Reviews · doi:10.1152/physrev.00031.2014 · Cited by 578
“GLP-1 is also produced by a small group of neurons located in the NTS (72, 128, 222, 336).”
BackgroundGut microbiota, obesity and diabetes
Patterson, E., Ryan, P. M., Cryan, J. F., Dinan, T. G., Ross, R. P., Fitzgerald, G. F., & Stanton, C. (2016) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2015-133285 · Cited by 552
International Union of Pharmacology. XXXV. The Glucagon Receptor Family
Mayo, K. E., Miller, L. J., Bataille, D., Dalle, S., Göke, B., Thorens, B., & Drucker, D. J. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.6 · Cited by 506
ØRSKOV, C., HOLST, J. J., KNUHTSEN, S., BALDISSERA, F. G. A., POULSEN, S. S., & NIELSEN, O. V. (1986) · Endocrinology · doi:10.1210/endo-119-4-1467 · Cited by 482
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Zhao, X., Wang, M., Wen, Z., Lu, Z., Cui, L., Fu, C., Xue, H., Liu, Y., & Zhang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.721135 · Cited by 463
“Long term use of beinaglutide, a recombinant human GLP-1(7-36) acid, was demonstrated to reduce the body weight and improve steatosis (194).”
BackgroundInfluentialIncretins, insulin secretion and Type 2 diabetes mellitus
Vilsbøll, T., & Holst, J. J. (2004) · Diabetologia · doi:10.1007/s00125-004-1342-6 · Cited by 444
Wei, Y., & Mojsov, S. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01430-9 · Cited by 450
The New Biology and Pharmacology of Glucagon
Müller, T. D., Finan, B., Clemmensen, C., DiMarchi, R. D., & Tschöp, M. H. (2017) · Physiological Reviews · doi:10.1152/physrev.00025.2016 · Cited by 419
“It gives rise to a series of peptide hormones that include glicentin [amino acids (aa) 1–69], glicentin-related pancreatic polypeptide (GRPP; aa 1–30), oxyntomodulin (OXM; aa 33–69), and the glucagon-like peptides 1 (GLP-1; aa 72–107/108) and 2 (GLP-2; aa 126–158) (FIGURE 2) (46, 157, 434).”
BackgroundDiscovery, characterization, and clinical development of the glucagon-like peptides
Drucker, D. J., Habener, J. F., & Holst, J. J. (2017) · Journal of Clinical Investigation · doi:10.1172/jci97233 · Cited by 418
Graaf, C. D., Donnelly, D., Wootten, D., Lau, J., Sexton, P. M., Miller, L. J., Ahn, J.-M., Liao, J., Fletcher, M. M., Yang, D., et al. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011395 · Cited by 403
ØRSKOV, C., HOLST, J. J., & NIELSEN, O. V. (1988) · Endocrinology · doi:10.1210/endo-123-4-2009 · Cited by 396
Attenuated GLP-1 secretion in obesity: cause or consequence
Ranganath, L. R., Beety, J. M., Morgan, L. M., Wright, J. W., Howland, R., & Marks, V (1996) · Gut · doi:10.1136/gut.38.6.916 · Cited by 394
Nauck, M. A., Quast, D. R., Wefers, J., & Pfeiffer, A. F. H. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14496 · Cited by 388
Orskov, C., Jeppesen, J., Madsbad, S., & Holst, J. J. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115012 · Cited by 378
Dunning, B. E., & Gerich, J. E. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0026 · Cited by 369
The New Biology of Gastrointestinal Hormones
REHFELD, J. F. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.4.1087 · Cited by 329
Jin, S. ‐. C., Han, V. K. M., Simmons, J. G., Towle, A. C., Lauder, J. M., & Lund, P. K. (1988) · Journal of Comparative Neurology · doi:10.1002/cne.902710405 · Cited by 335
Buxbaum, J. N., Dispenzieri, A., Eisenberg, D. S., Fändrich, M., Merlini, G., Saraiva, M. J. M., Sekijima, Y., & Westermark, P. (2022) · Amyloid · doi:10.1080/13506129.2022.2147636 · Cited by 313
Schmidt, W. E., Siegel, E. G., & Creutzfeldt, W. (1985) · Diabetologia · doi:10.1007/bf00291980 · Cited by 319
The Glucagonoma Syndrome Clinical and Pathologic Features in 21 Patients
Wermers, R. A., Fatourechi, V., Wynne, A. G., Kvols, L. K., & Lloyd, R. V. (1996) · Medicine · doi:10.1097/00005792-199603000-00002 · Cited by 322
Yang, S. Y., & Goldspink, G. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02918-6 · Cited by 322
Drucker, D. J. (1994) · Molecular Endocrinology · doi:10.1210/me.8.12.1646 · Cited by 302
SEEBURG, P. H. (1982) · DNA · doi:10.1089/dna.1.1982.1.239 · Cited by 298
Sonne, D. P., Engstrøm, T., & Treiman, M. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2007.10.001 · Cited by 294
Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation
McLean, B. A., Wong, C. K., Campbell, J. E., Hodson, D. J., Trapp, S., & Drucker, D. J. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnaa032 · Cited by 289
“The cloning of the proglucagon cDNAs encoding GLP-1 within the proglucagon (GCG) gene in the early 1980s (2, 3), enabled the study of the physiology of”
BackgroundGlucagon-like peptide-1, a new hormone of the entero-insular axis
Ørskov, C. (1992) · Diabetologia · doi:10.1007/bf00429088 · Cited by 293
Alpha cell function in health and disease: influence of glucagon-like peptide-1
Dunning, B. E., Foley, J. E., & Ahrén, B. (2005) · Diabetologia · doi:10.1007/s00125-005-1878-0 · Cited by 271
GLP-1-based therapies for diabetes, obesity and beyond
Drucker, D. J. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01183-8 · Cited by 236
Holst, J. J. (1997) · Annual Review of Physiology · doi:10.1146/annurev.physiol.59.1.257 · Cited by 267
Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
Liu, Q. K. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1431292 · Cited by 265
“In 1983, Bell et al. reported the human and hamster GLP-1 gene and the deduced peptide sequences using cDNA hybridization technology and analysis of the human preproglucagon gene (20, 21).”
MethodGlucagon gene expression in vertebrate brain.
Drucker, D. J., & Asa, S. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68261-4 · Cited by 264
MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes?
Nauck, M. A., & Meier, J. J. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0566 · Cited by 254
VIP: Molecular biology and neurobiological function
Gozes, I., & Brenneman, D. E. (1989) · Molecular Neurobiology · doi:10.1007/bf02740606 · Cited by 255
Glucagonlike peptide 1: a newly discovered gastrointestinal hormone
Holst, J. J. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90831-1 · Cited by 252
GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach
Wang, J.-Y., Wang, Q.-W., Yang, X.-Y., Yang, W., Li, D.-R., Jin, J.-Y., Zhang, H.-C., & Zhang, X.-F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1085799 · Cited by 248
The expanding incretin universe: from basic biology to clinical translation
Drucker, D. J., & Holst, J. J. (2023) · Diabetologia · doi:10.1007/s00125-023-05906-7 · Cited by 243
“Graeme Bell and colleagues identified the sequences of hamster and human proglucagon [24, 25], with other labs rapidly elucidating the bovine [26] and rat [27] proglucagon sequences.”
BackgroundBiologic actions and therapeutic potential of the proglucagon-derived peptides
Drucker, D. J. (2005) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0017 · Cited by 230
Gut peptides and the regulation of appetite
Huda, M. S. B., Wilding, J. P. H., & Pinkney, J. H. (2006) · Obesity Reviews · doi:10.1111/j.1467-789x.2006.00245.x · Cited by 223
Signals for the selection of a splice site in pre-mRNA
Ohshima, Y., & Gotoh, Y. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90647-4 · Cited by 235
Glucagon-like peptide-1: From extract to agent. The Claude Bernard Lecture, 2005
Holst, J. J. (2006) · Diabetologia · doi:10.1007/s00125-005-0107-1 · Cited by 228
Proglucagon is processed to glucagon by prohormone convertase PC2 in alpha TC1-6 cells.
Rouillé, Y., Westermark, G., Martin, S. K., & Steiner, D. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3242 · Cited by 221
Structure, measurement, and secretion of human glucagon-like peptide-2
Hartmann, B., Johnsen, A. H., Ørskov, C., Adelhorst, K., Thim, L., & Holst, J. J. (2000) · Peptides · doi:10.1016/s0196-9781(99)00176-x · Cited by 221
Glucagon-Like Peptide-2 Inhibits Centrally Induced Antral Motility in Pigs
M. WØJDEMANN, A. W. (1998) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529850171486 · Cited by 210
Glucagon gene sequence. Four of six exons encode separate functional domains of rat pre-proglucagon
Heinrich, G., Gros, P., & Habener, J. F. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89859-3 · Cited by 207
Pancreatic and intestinal processing of proglucagon in man
Ørskov, C., Holst, J. J., Poulsen, S. S., & Kirkegaard, P. (1987) · Diabetologia · doi:10.1007/bf00274797 · Cited by 210
Reimer, R. A. (1996) · Endocrinology · doi:10.1210/en.137.9.3948 · Cited by 207
GLP-1: Molecular mechanisms and outcomes of a complex signaling system
Smith, N. K., Hackett, T. A., Galli, A., & Flynn, C. R. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.04.010 · Cited by 188
Complete Sequences of Glucagon-like Peptide-1 from Human and Pig Small Intestine
Orskov, C., Bersani, M., Johnsen, A. H., Højrup, P., & Holst, J. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51561-1 · Cited by 210
Structure of pre-pro-von Willebrand factor and its expression in heterologous cells
Bonthron, D. T., Handin, R. I., Kaufman, R. J., Wasley, L. C., Orr, E. C., Mitsock, L. M., Ewenstein, B., Loscalzo, J., Ginsburg, D., & Orkin, S. H. (1986) · Nature · doi:10.1038/324270a0 · Cited by 203
Brubaker, P. L., & Drucker, D. J. (2002) · Receptors and Channels · doi:10.1080/10606820213687 · Cited by 198
Massimino, S. P., McBurney, M. I., Field, C. J., Thomson, A. B. R., Keelan, M., Hayek, M. G., & Sunvold, G. D. (1998) · The Journal of Nutrition · doi:10.1093/jn/128.10.1786 · Cited by 186
Wettergren, A., Wøjdemann, M., & Holst, J. J. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.5.g984 · Cited by 197
GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice
Hansotia, T., & Drucker, D. J. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2004.07.019 · Cited by 183
Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut
Böttcher, G., Sjölund, K., Ekblad, E., Håkanson, R., Schwartz, T. W., & Sundler, F. (1984) · Regulatory Peptides · doi:10.1016/0167-0115(84)90034-x · Cited by 190
Reappraisal of GIP Pharmacology for Metabolic Diseases
Finan, B., Müller, T. D., Clemmensen, C., Perez-Tilve, D., DiMarchi, R. D., & Tschöp, M. H. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.03.005 · Cited by 180
Schjoldager, B. T. G., Mortensen, P. E., Christiansen, J., �rskov, C., & Holst, J. J. (1989) · Digestive Diseases and Sciences · doi:10.1007/bf01540341 · Cited by 178
Proglucagon processing in porcine and human pancreas.
Holst, J. J., Bersani, M., Johnsen, A. H., Kofod, H., Hartmann, B., & Orskov, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32241-x · Cited by 181
Gut hormones and diabetes mellitus
Creutzfeldt, W., & Nauck, M. (1992) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610080206 · Cited by 176
Structural Organization and Chromosomal Assignment of the Gene Encoding Endothelin
Bloch, K. D., Friedrich, S. P., Lee, M. E., Eddy, R. L., Shows, T. B., & Quertermous, T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81698-2 · Cited by 177
Peptide YY abnormalities in gastrointestinal diseases
Adrian, T. E., Savage, A. P., Bacarese-Hamilton, A. J., Wolfe, K., Besterman, H. S., & Bloom, S. R. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90936-4 · Cited by 176
Identification and Localization of Glucagon-Like Peptide-1 and Its Receptor in Rat Brain*
SHIMIZU, I., HIROTA, M., OHBOSHI, C., & SHIMA, K. (1987) · Endocrinology · doi:10.1210/endo-121-3-1076 · Cited by 174
Neuropeptide families: evolutionary perspectives
Hoyle, C. H. V. (1998) · Regulatory Peptides · doi:10.1016/s0167-0115(97)01073-2 · Cited by 166
Glucagon gene regulatory region directs oncoprotein expression to neurons and pancreatic a cells
Efrat, S., Teitelman, G., Anwar, M., Ruggiero, D., & Hanahan, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90110-9 · Cited by 164
Yi, F., Sun, J., Lim, G. E., Fantus, I. G., Brubaker, P. L., & Jin, T. (2008) · Endocrinology · doi:10.1210/en.2007-1142 · Cited by 157
Therapy of type 2 diabetes mellitus based on the actions of glucagon‐like peptide‐1
Holst, J. J. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.328 · Cited by 155
Wettergren, A., Wøjdemann, M., Meisner, S., Stadil, F., & Holst, J. J. (1997) · Gut · doi:10.1136/gut.40.5.597 · Cited by 153
Miholic, J., �rskov, C., Holst, J. J., Kotzerke, J., & Meyer, H.-J. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01296800 · Cited by 163
From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy
Holst, J. J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00260 · Cited by 147
Intestinal Fructose and Glucose Metabolism in Health and Disease
Merino, B., Fernández-Díaz, C. M., Cózar‐Castellano, I., & Perdomo, G. (2019) · Nutrients · doi:10.3390/nu12010094 · Cited by 166
Targeting the glucagon receptor family for diabetes and obesity therapy
Cho, Y. M., Merchant, C. E., & Kieffer, T. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.05.009 · Cited by 156
The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective
Jensterle, M., Janez, A., Fliers, E., DeVries, J. H., Vrtacnik-Bokal, E., & Siegelaar, S. E. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz019 · Cited by 128
Vrang, N., & Larsen, P. J. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.07.003 · Cited by 153
Receptor‐mediated activation of gastric vagal afferents by glucagon‐like peptide‐1 in the rat
Bucinskaite, V., Tolessa, T., Pedersen, J., Rydqvist, B., Zerihun, L., Holst, J. J., & Hellström, P. M. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01317.x · Cited by 135
Kilimnik, G., Kim, A., Steiner, D. F., Friedman, T. C., & Hara, M. (2010) · Islets · doi:10.4161/isl.2.3.11396 · Cited by 137
Proglucagon gene expression is regulated by a cyclic AMP-dependent pathway in rat intestine.
Drucker, D. J., & Brubaker, P. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.11.3953 · Cited by 134
Glucagon-like peptide-2 increases mesenteric blood flow in humans
Bremholm, L., Hornum, M., Henriksen, B. M., Larsen, S., & Holst, J. J. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802538195 · Cited by 142
Glucagon‐like Peptide‐2 and the Regulation of Intestinal Growth and Function
Brubaker, P. L. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170055 · Cited by 138
Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism
Bu, T., Sun, Z., Pan, Y., Deng, X., & Yuan, G. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0277 · Cited by 131
Varndell, I. M., Bishop, A. E., Sikri, K. L., Uttenthal, L. O., Bloom, S. R., & Polak, J. M. (1985) · Journal of Histochemistry & Cytochemistry · doi:10.1177/33.10.3900195 · Cited by 130
Montero‐Hadjadje, M., Yon, L., Kikuyama, S., Dufour, S., & Vaudry, H. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0250157 · Cited by 131
Glucagon – Early breakthroughs and recent discoveries
Åhrén, B. (2015) · Peptides · doi:10.1016/j.peptides.2015.03.011 · Cited by 134
Holst, J. J. (1999) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(99)00157-5 · Cited by 146
Metadata
- Authors
- Bell, G. I., Sanchez-Pescador, R., Laybourn, P. J., & Najarian, R. C.
- ORCID
- Laybourn, Paul J.
- Venue
- Nature
- Published
- 1983-07
- Volume
- 304
- Issue
- 5924
- Pages
- 368-371
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2003141714
- Cited by
- 593
- References
- 36
- Citations by year
- 2026: 16 · 2025: 21 · 2024: 21 · 2023: 17 · 2022: 12 · 2021: 16 · 2020: 13 · 2019: 17 · 2018: 14 · 2017: 10 · 2016: 16 · 2015: 10 · 2014: 12 · 2013: 8 · 2012: 13
- FWCI
- 36.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- exon duplication, glucagon, glucagon-like peptide-1, glucagon-like peptide-2, signal peptide, gene structure
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Glucagon, Cricetinae, Humans, Insulin, Proinsulin, Protein Precursors, Proglucagon
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.